Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- TSVT
- Price
- 5.00
- Stock movement up
- +- (%)
- Company name
- 2Seventy Bio Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 266.14M
- Ent value
- 481.90M
- Price/Sales
- 5.83
- Price/Book
- 1.17
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- 22.22
- PEG
- -
- EPS growth
- -
- 1 year return
- 14.16%
- 3 year return
- -27.05%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-09-15
DIVIDENDS
TSVT does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 5.83 |
| Price to Book | 1.17 |
| EV to Sales | 10.56 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 53.23M |
| EPS (TTM) | -1.81 |
| FCF per share (TTM) | -2.70 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 45.62M |
| Gross profit (TTM) | 23.62M |
| Operating income (TTM) | -142.83M |
| Net income (TTM) | -94.55M |
| EPS (TTM) | -1.81 |
| EPS (1y forward) | 0.23 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 51.77% |
| Operating margin (TTM) | -313.09% |
| Profit margin (TTM) | -207.25% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 59.98M |
| Net receivables | 22.27M |
| Total current assets | 218.48M |
| Goodwill | 0.00 |
| Intangible assets | 6.06M |
| Property, plant and equipment | 0.00 |
| Total assets | 503.85M |
| Accounts payable | 5.08M |
| Short/Current long term debt | 247.45M |
| Total current liabilities | 44.09M |
| Total liabilities | 275.74M |
| Shareholder's equity | 228.10M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -139.12M |
| Capital expenditures (TTM) | 1.78M |
| Free cash flow (TTM) | -140.90M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -41.45% |
| Return on Assets | -18.77% |
| Return on Invested Capital | -38.77% |
| Cash Return on Invested Capital | -57.77% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 5.00 |
| Daily high | 5.00 |
| Daily low | 5.00 |
| Daily Volume | 0K |
| All-time high | 42.56 |
| 1y analyst estimate | 5.00 |
| Beta | 1.05 |
| EPS (TTM) | -1.81 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| TSVT | S&P500 | |
| Current price drop from All-time high | -88.25% | -4.87% |
| Highest price drop | -96.31% | -56.47% |
| Date of highest drop | 21 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -77.48% | -10.99% |
| Avg time to new high | 178 days | 12 days |
| Max time to new high | 887 days | 1805 days |
COMPANY DETAILS
Marketcap
266.14M
Marketcap category
Small-cap
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. 2seventy bio, Inc. was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
Employees
65
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner